Yaya Barry

Yaya Barry

Auto-generated profile, based on publicly available information

Yaya Barry

Santé publique France, the national public health agency, Saint-Maurice, France

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2024 in Diabetologia
Verified
Journal Article
Open access
PDF file
NRNolwenn Regnault
Nolwenn Regnault
ELElodie Lebreton
Elodie Lebreton
LTLuveon Tang
Luveon Tang
SFSandrine Fosse-Edorh
Sandrine Fosse-Edorh
YBYaya Barry
Yaya Barry
ECEmmanuel Cosson
Emmanuel Cosson
Aims/hypothesis: We aimed to assess maternal–fetal outcomes according to various subtypes of hyperglycaemia in pregnancy. Methods: We used data from the French National Health Data System (Système National des Données de Santé), which links individual data from the hospital discharge database and the French National Health Insurance information system. We included all deliveries after 22 gestational weeks (GW) in women without pre-existing diabetes recorded in 2018. Women with hyperglycaemia were classified as having overt diabetes in pregnancy or gestational diabetes mellitus (GDM), then categorised into three subgroups according to their gestational age at the time of GDM diagnosis: before 22 GW (GDM<22); between 22 and 30 GW (GDM22–30); and after 30 GW (GDM>30). Adjusted prevalence ratios (95% CI) for the outcomes were estimated after adjusting for maternal age, gestational age and socioeconomic status. Due to the multiple tests, we considered an association to be statistically significant according to the Holm–Bonferroni procedure. To take into account the potential immortal time bias, we performed analyses on deliveries at ≥31 GW and deliveries at ≥37 GW. Results: The study population of 695,912 women who gave birth in 2018 included 84,705 women (12.2%) with hyperglycaemia in pregnancy: overt diabetes in pregnancy, 0.4%; GDM<22, 36.8%; GDM22–30, 52.4%; and GDM>30, 10.4%. The following outcomes were statistically significant after Holm–Bonferroni adjustment for deliveries at ≥31 GW using GDM22–30 as the reference. Caesarean sections (1.54 [1.39, 1.72]), large-for-gestational-age (LGA) infants (2.00 [1.72, 2.32]), Erb’s palsy or clavicle fracture (6.38 [2.42, 16.8]), preterm birth (1.84 [1.41, 2.40]) and neonatal hypoglycaemia (1.98 [1.39, 2.83]) were more frequent in women with overt diabetes. Similarly, LGA infants (1.10 [1.06, 1.14]) and Erb’s palsy or clavicle fracture (1.55 [1.22, 1.99]) were more frequent in GDM<22. LGA infants (1.44 [1.37, 1.52]) were more frequent in GDM>30. Finally, women without hyperglycaemia in pregnancy were less likely to have preeclampsia or eclampsia (0.74 [0.69, 0.79]), Caesarean section (0.80 [0.79, 0.82]), pregnancy and postpartum haemorrhage (0.93 [0.89, 0.96]), LGA neonate (0.67 [0.65, 0.69]), premature neonate (0.80 [0.77, 0.83]) and neonate with neonatal hypoglycaemia (0.73 [0.66, 0.82]). Overall, the results were similar for deliveries at ≥37 GW. Although the estimation of the adjusted prevalence ratio of perinatal death was five times higher (5.06 [1.87, 13.7]) for women with overt diabetes, this result was non-significant after Holm–Bonferroni adjustment. Conclusions/interpretation: Compared with GDM22–30, overt diabetes, GDM<22 and, to a lesser extent, GDM>30 were associated with poorer maternal–fetal outcomes. Graphical

9 May 2022 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YBYaya Barry
Yaya Barry
YSYann Le Strat
Yann Le Strat
EAElie Azria
Elie Azria
MGMaud Gorza
Maud Gorza
HPHugo Pilkington
Hugo Pilkington
NRNolwenn Regnault
Nolwenn Regnault
Background: Evidence-based policy-making to reduce perinatal health inequalities requires an accurate measure of social disparities. We aimed to evaluate the relevance of two municipality-level deprivation indices (DIs), the French-Deprivation-Index (FDep) and the French-European-Deprivation-Index (FEDI) in perinatal health through two key perinatal outcomes: preterm birth (PTB) and small-for-gestational-age (SGA). Methods: We used two data sources: The French National Perinatal Surveys (NPS) and the French national health data system (SNDS). Using the former, we compared the gradients of the associations between individual socioeconomic characteristics (educational level and income) and “PTB and SGA” and associations between municipality-level DIs (Q1:least deprived; Q5:most deprived) and “PTB and SGA”. Using the SNDS, we then studied the association between each component of the two DIs (census data, 2015) and “PTB and SGA”. Adjusted odds ratios (aOR) were estimated using multilevel logistic regression with random intercept at the municipality level. Results: In the NPS (N = 26,238), PTB and SGA were associated with two individual socioeconomic characteristics: maternal educational level (≤ lower secondary school vs. ≥ Bachelor’s degree or equivalent, PTB: aOR = 1.43 [1.22–1.68], SGA: (1.31 [1.61–1.49]) and household income (< 1000 € vs. ≥ 3000 €, PTB: 1.55 [1.25–1.92], SGA: 1.69 [1.45–1.98]). For both FDep and FEDI, PTB and SGA were more frequent in deprived municipalities (Q5: 7.8% vs. Q1: 6.3% and 9.0% vs. 5.9% for PTB, respectively, and 12.0% vs. 10.3% and 11.9% vs. 10.2% for SGA, respectively). However, after adjustment, neither FDep nor FEDI showed a significant gradient with PTB or SGA. In the SNDS (N = 726,497), no FDep component, and only three FEDI components were significantly associated (specifically, the % of the population with ≤ lower secondary level of education with both outcomes (PTB: 1.5 [1.15–1.96]); SGA: 1.25 [1.03–1.51]), the % of overcrowded (i.e., > 1 person per room) houses (1.63 [1.15–2.32]) with PTB only, and unskilled farm workers with SGA only (1.52 [1.29–1.79]). Conclusion: Some components of FDep and FEDI were less relevant than others for capturing ecological inequalities in PTB and SGA. Results varied for each DI and perinatal outcome studied. These findings highlight the importance of testing DI relevance prior to examining perinatal health inequalities, and suggest the need to develop DIs that are suitable for pregnant women.

27 November 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
YBYaya Barry
Yaya Barry
LMLaurence Mandereau-Bruno
Laurence Mandereau-Bruno
CBChristophe Bonaldi
Christophe Bonaldi
DCDavid Cheillan
David Cheillan
RCRégis Coutant
Régis Coutant
NRNolwenn Regnault
Nolwenn Regnault
Context: The increase in the incidence of congenital hypothyroidism (CH) reported worldwide may partly be explained by an increase in the transient form of CH. Objective: We aimed to estimate the proportion of transient CH (TCH) in France, and to identify associated neonatal and young child characteristics. Methods: We used probabilistic record linkage to link children with eutopic gland born between 2006 and 2012 recorded in the national French CH registry and the French national health data system (SNDS). Of the 703 children recorded, 484 (68.8%) were linked. We retrospectively examined reimbursement for oral levothyroxine (LT4) between January 1, 2006, and December 31, 2017. Children who had discontinued treatment for 6 months or more before December 31, 2017, were classified as having TCH. We used a Cox model to examine the factors associated with TCH. Results: Among the main study sample (n = 471), 53.5% were female, 14.2% were preterm, and 13.8% had low birth weight. One-quarter (n = 111, 24.3%) had mild CH (thyroid-stimulating hormone [TSH] < 50 mU/L, serum) at diagnosis and a median LT4 dose at treatment initiation of 30 μg/day. One-third (n = 155, 32.9%) had TCH. Premature birth (adjusted hazard ratio = 2.1 [1.0–4.2]), a TSH < 50 mU/L at CH screening (7.4 [3.2–17.1]), LT4 dose received at 12 months of age (0.98 [0.97–0.99, P = 0.003]), congenital cardiac malformations (6.6 [1.5–29.0]), and year of birth (1.2 [1.1–1.4]) were all associated with TCH. Conclusion: One-third of the children had TCH, and it was associated with several characteristics at birth and postpartum. These data are useful for CH medical management and epidemiological surveillance.

1 August 2019 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
YBY. Barry
Y. Barry
CDC. Deneux-Tharaux
C. Deneux-Tharaux
MSM. Saucedo
M. Saucedo
VGV. Goulet
V. Goulet
IGI. Guseva-Canu
I. Guseva-Canu
ACA.A. Chantry
A.A. Chantry

1 October 2017 in Revue D'Épidémiologie Et de Santé Publique
Verified
Journal Article
Closed access
ASA. Serfaty
A. Serfaty
SBS. Baron
S. Baron
CCC. Crenn-Hebert
C. Crenn-Hebert
YBY. Barry
Y. Barry
STS. Tala
S. Tala

Verified
Dataset
Open access
HBHaikel N. Bogale
Haikel N. Bogale
MCMatthew V. Cannon
Matthew V. Cannon
KKKalil Keita
Kalil Keita
DCDenka Camara
Denka Camara
YBYaya Barry
Yaya Barry
DSDavid Serre
David Serre
Additional file 12: Table S6: Eukaryotic parasite and virus identification. Table shows the primer name, sample name, collection site, mosquito species, and taxonomic information per sequence identified. Table also gives, for each sequence, the frequency per sample (count), percentage match to NCBI database (% Identity), length of sequence (in bp), and length of the match (in bp) to NCBI sequence